The Use of Anti-Tumor Necrosis Factor Agents and Development of Psoriasis in Patients with Crohn's Disease

被引：0
|
作者：
Lin, Ming [1 ]
Blonski, Wojciech [2 ]
Weiner, Mark [2 ]
Tierney, Ann [2 ]
Marchioni, Renee [3 ]
Buchner, Anna [2 ]
Lichtenstein, Gary [2 ]
机构：
[1] Univ Cincinnati, Div Digest Dis, Cincinnati, OH USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Penn Hosp, Philadelphia, PA 19107 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2011年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1289
引用
收藏
页码：S490 / S491
页数：2
相关论文
共 50 条
  • [41] A cost-efficacy analysis model for physician administered anti-tumor necrosis factor agents in Crohn's disease
    Waters, H.
    McKenzie, R.
    Tang, B.
    Piech, C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S393 - S393
  • [42] Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents
    Eickstaedt, Joshua B.
    Killpack, Luke
    Tung, Jeanne
    Davis, Dawn
    Hand, Jennifer L.
    Tollefson, Megha M.
    PEDIATRIC DERMATOLOGY, 2017, 34 (03) : 253 - 260
  • [43] Infliximab-Associated Psoriasis in Children With Crohn's Disease May Require Withdrawal of Anti-Tumor Necrosis Factor Therapy
    Broge, Tangra
    Nam Nguyen
    Sacks, Alan
    Davis, Michael
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (05) : E75 - E77
  • [44] Rates of tuberculosis infection in Crohn's Disease patients before and during anti-tumor necrosis factor therapy
    Georgieva, A. C.
    Atanassova, A.
    Mirchev, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I410 - I411
  • [45] Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients
    Syed, Ali
    Cross, Raymond K.
    Flasar, Mark H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (04): : 583 - 593
  • [46] Rates of tuberculosis infection in Crohn's Disease patients before and during anti-tumor necrosis factor therapy
    Georgieva, A. C.
    Atanassova, A.
    Mirchev, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I410 - I411
  • [47] Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
    Park, Jihye
    Cheon, Jae Hee
    GUT AND LIVER, 2021, 15 (05) : 641 - 642
  • [48] Mycobacterial Disease in Patients Who Use Anti-Tumor Necrosis Factor Therapy
    Winthrop, Kevin L.
    Baxter, Roger
    Liu, Liyan
    McFarland, Bentson
    Austin, Donald F.
    Varley, Cara D.
    Radcliffe, LeAnn
    Suhler, Eric B.
    Choi, Dongseok
    Rosenbaum, James T.
    Herrinton, Lisa J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S86 - S86
  • [49] The relation between outcomes of laparoscopic surgery and the duration of preoperative treatment with anti-tumor necrosis factor alpha agents for Crohn's disease patients
    Morimoto, Yoshihiro
    Mizushima, Tsunekazu
    Hata, Tsuyoshi
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Yamamoto, Hirofumi
    Mori, Masaki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 307 - 307
  • [50] Antinuclear antibody formation following administration of anti-tumor necrosis factor agents in Japanese patients with psoriasis
    Yanaba, Koichi
    Umezawa, Yoshinori
    Honda, Hiromi
    Sato, Reiko
    Chiba, Miki
    Kikuchi, Sota
    Asahina, Akihiko
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2016, 43 (04): : 443 - 444
12345